ANI Pharma (ANIP) - Gross Profit Rate

Official company branding of ANI Pharma (ANIP)

The gross profit margin reflects the operational efficiency of ANI Pharmaceuticals (ANIP), where the 53.10 mark indicates the current status. Stable revenue is driven by demand for rare dosages of chronic medications. Portfolio growth is supported by licensing agreements and distributor partnerships. New generic lines and an expanding share of specialized gels are currently driving the momentum.

anipharmaceuticals.com - ANIP Gross Margin (period 07/04/2022 - 11/20/2026)

Analytical breakdowns and data insights for company ANI Pharmaceuticals (ANIP)

- current quotes and average value forecast:
Basic company analysis:ANIP, ANI Pharmaceuticals, Inc.
Manufactured product of ANI Pharmaceuticals Corp

The scaling dynamics of generics and the development of the orphan portfolio at ANI Pharmaceuticals (ANIP) are directly reflected in the gross margin. This indicator measures the portion of revenue remaining after deducting all direct production costs, allowing investors to assess cost management efficiency and the business's solvency amid market turbulence, where high volatility of the metric signals risks of capital impairment.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Return on Sales by Gross Profit Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Gross Profitability|Gross Return on Sales MNKD|Gross Profitability Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Return on Sales by Gross Profit|Gross Margin SPRY|TBPH - Gross Profit Margin|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin